You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Drug Price Trends for NDC 42192-0340


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 42192-0340

Drug Name NDC Price/Unit ($) Unit Date
HYOSCYAMINE SULF 0.125 MG TAB 42192-0340-01 0.14488 EACH 2024-12-18
HYOSCYAMINE SULF 0.125 MG TAB 42192-0340-01 0.09933 EACH 2024-11-20
HYOSCYAMINE SULF 0.125 MG TAB 42192-0340-01 0.18013 EACH 2024-10-23
HYOSCYAMINE SULF 0.125 MG TAB 42192-0340-01 0.18975 EACH 2024-09-18
HYOSCYAMINE SULF 0.125 MG TAB 42192-0340-01 0.18785 EACH 2024-08-21
HYOSCYAMINE SULF 0.125 MG TAB 42192-0340-01 0.13631 EACH 2024-07-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 42192-0340

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

42192-0340 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 42192-0340

Introduction

The drug identified by the National Drug Code (NDC) 42192-0340 is a pharmaceutical product that requires a thorough market analysis to understand its pricing dynamics and project future price trends. Here, we will delve into various factors influencing the market and pricing of this drug.

Drug Identification and Classification

To begin, it is crucial to identify the drug associated with NDC 42192-0340. While the specific details of this NDC are not provided in the sources, understanding the general classification and therapeutic category of the drug is essential.

  • Generic or Brand Name: Determine whether the drug is a generic or brand name product. This distinction significantly impacts pricing strategies and market dynamics[2].

Market Share and Pricing Impact

Medicare's Market Share

Medicare's influence on drug pricing cannot be overlooked, especially if the drug falls under Medicare Part B or Part D.

  • Medicare's Dominance: If Medicare has a substantial market share for this drug, it could reduce competitive pricing pressures. Manufacturers may have greater flexibility to set prices without fearing significant sales declines, particularly if the drug is a single-source product[2].

Other Payers and Market Segments

In addition to Medicare, other payers such as private insurance companies and government programs like the 340B Drug Pricing Program can influence pricing.

  • 340B Program: This program requires drug companies to offer discounted prices on certain outpatient drugs to eligible hospitals. While the discounts are a small share of drug company revenues, they can impact the overall pricing strategy[4].

Industry Trends and Price Erosion

Generic Drug Sector

For generic drugs, mid-single-digit percent annual price erosion is common, along with modest revenue growth.

  • Price Erosion: If NDC 42192-0340 is a generic drug, it may experience price erosion over time. However, the median price increase for generic drugs can be significant, as seen in the case of a generic naproxen with a 2,527% price increase[1].

Branded and Specialty Drugs

For branded and specialty drugs, the picture is different. These drugs often maintain higher prices due to their unique therapeutic benefits and lack of direct generic competition.

  • Biosimilars and Competition: The introduction of biosimilars can influence pricing strategies, but if NDC 42192-0340 is a unique product, it may be less affected by this competition[2].

Market Growth and Technological Advancements

Drug Delivery Systems

The market for drug delivery devices, including injectables and other administration routes, is expected to grow significantly.

  • Injectables: If NDC 42192-0340 is administered via injection or another growing delivery method, this could support higher pricing due to increased demand and technological advancements in drug delivery systems[2].

Price Projections

Factors Influencing Pricing

Several factors will influence the price projections for NDC 42192-0340:

  • Medicare Negotiations: If Medicare has a significant market share, negotiated prices under the Medicare Drug Price Negotiation Program could set a benchmark for future pricing discussions[2].

  • Industry Trends: The generic drug sector's price erosion does not directly impact branded or specialty drugs. However, the overall market trends, including the growth in demand for advanced drug delivery systems, will support higher pricing[2].

  • Competition and Market Dynamics: The presence of direct competitors or biosimilars can impact pricing. However, if NDC 42192-0340 is a unique product, it may maintain higher prices despite competitive pressures[2].

Quality of Information and Transparency

The quality of information submitted by manufacturers can vary significantly, which affects the accuracy of price analyses.

  • Transparency Issues: Manufacturers may refuse to provide detailed information or offer generalized descriptions, making it challenging to determine the reasons for price increases[1].

Regulatory and Legislative Impacts

Changes in legislation and regulatory policies can significantly impact the pricing and availability of drugs.

  • Patent and Exclusivity Policies: Changes to patent and extended exclusivity policies can affect the pricing strategy for NDC 42192-0340. Expansions or reductions in exclusivity periods can influence competitive dynamics and pricing[4].

Technological and Data Trends

The adoption of artificial intelligence (AI) and the use of external data are becoming increasingly important in the pharmaceutical industry.

  • AI in Clinical Development: The use of AI in standard operations in clinical development is expected to double in 2025, which could impact the development and pricing of new drugs[3].

  • External Data and AI Models: Pharmaceutical companies are turning to reliable external data to train internal data science models, including large language models (LLMs). This trend can enhance decision-making and potentially influence pricing strategies[3].

Key Takeaways

  • Medicare's Market Share: Significant market share can reduce competitive pricing pressures.
  • Industry Trends: Branded and specialty drugs are less affected by generic price erosion.
  • Market Growth: Growing demand for advanced drug delivery systems supports higher pricing.
  • Regulatory and Legislative Impacts: Changes in patent and exclusivity policies can affect pricing strategies.
  • Technological Trends: The increasing use of AI and external data can enhance decision-making and influence pricing.

FAQs

Q: How does Medicare's market share affect drug pricing? A: Medicare's significant market share can reduce competitive pricing pressures, allowing manufacturers to set prices with greater flexibility, especially for single-source products[2].

Q: What is the impact of the 340B Drug Pricing Program on drug companies? A: The 340B program requires drug companies to offer discounted prices, but these discounts are a small share of drug company revenues and do not significantly impact their overall revenue growth[4].

Q: How do industry trends in drug delivery systems affect pricing? A: The growing demand for injectable and other advanced drug delivery systems supports higher pricing due to increased demand and technological advancements[2].

Q: What role does AI play in the pharmaceutical industry's pricing strategies? A: AI is increasingly used in clinical development and decision-making, which can influence pricing strategies by enhancing the accuracy and efficiency of data analysis[3].

Q: How do changes in regulatory policies impact drug pricing? A: Changes in patent and extended exclusivity policies can affect competitive dynamics and pricing strategies for drugs like NDC 42192-0340[4].

Sources

  1. Prescription Drug Price Transparency Results and Recommendations. Oregon Department of Consumer and Business Services, 2022.
  2. Market Analysis and Price Projections for Drug NDC: 00002-8147. Drug Patent Watch, 2024.
  3. 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch. Intelligencia.ai, 2024.
  4. The 340B Drug Pricing Program. American Hospital Association, 2024.
  5. NDC 42192-338 Oral Tablet, Orally Disintegrating Hyoscyamine Sulfate. FDA Report.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.